摘要
目的：探讨奥曲肽治疗乙肝后肝硬化失代偿顽固性腹水的疗效。方法：46例患者随机分为2组，对照组给予纠正低蛋白血症、利尿、维持电解质平衡、抗病毒等常规治疗。治疗组在上述基础上加用奥曲肽0.1mg 皮下注射 tid 。结果：治疗组相比对照组尿量增加、腹水减少，体重减轻。治疗组总体有效率为82.61%，明显高于对照组56.52%的治疗有效率。结论：奥曲肽在治疗乙肝后肝硬化顽固性腹水效果显著。
Abstract
Objective: To investigate octreotide treatment of decompensated liver cirrhosis with refractory ascites effect.Methods: 46 patients were randomly divided into two groups, a control group was given hypoproteinemia, diuretic, to maintain electrolyte balance, anti-virus and other conventional treatment. In the treatment group, based on the use of octreotide 0.1mg subcutaneous tid. Results: The treatment group compared to the control group to increase the amount of urine, ascites, weight loss. The overal effective rate of the treatment group 82.61%, significantly higher than 56.52% of the treatment efficiency.Conclusion:Octreotide in the treatment of liver cirrhosis with refractory ascites effect is remarkable.
NETL
NSTL
万方数据